Yu Jie, Wang Yang, Yu Xiaoling, Liang Ping
Department of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100853 China.
Hepatogastroenterology. 2010 May-Jun;57(99-100):451-5.
BACKGROUND/AIMS: The aim of this investigation was to describe the clinical features, diagnosis, pathologic characteristics, and optimal surgical management for patients with mucious hepatobiliary cystadenomas (HBCAs).
From 2005 to 2008, our institutional experience for treating six patients with HBCAs was reviewed and reported. The clinical features, radiological characteristics and management were analyzed retrospectively.
Two of six patients were respectively misdiagnosed as hydatid cyst and simple cyst pre-operatively. The histopathologic examination showed HBCA in four patients and hepatobiliary cystadenocaiconoma (HBCAC) in two patients. Three HBCA patients and two HBCAC patients had undergone total excision treatment. In a median of 37.5 months follow-up visit, four have no evidence of recurrence and one HBCAC patient experienced a recurrence 31 months after surgery. Another HBCA patient who underwent fenestration initially with subsequent recurrence, died 15 months after the therapy.
Owing to its potential for malignant transformation into HBCAC, along with the consideration that it tends to recur after incomplete resection, radical excision treatment with adequate surgical margins is regarded as the most suitable mode of therapy for the HBCA.
背景/目的:本研究旨在描述黏液性肝胆管囊腺瘤(HBCAs)患者的临床特征、诊断、病理特征及最佳手术治疗方法。
回顾并报告了2005年至2008年我院治疗6例HBCAs患者的经验。对其临床特征、影像学特征及治疗方法进行回顾性分析。
6例患者中,2例术前分别被误诊为包虫囊肿和单纯囊肿。组织病理学检查显示,4例为HBCA,2例为肝胆管囊腺癌(HBCAC)。3例HBCA患者和2例HBCAC患者接受了根治性切除术。在中位随访37.5个月时,4例无复发迹象,1例HBCAC患者术后31个月复发。另1例最初接受开窗术治疗后复发的HBCA患者,在治疗后15个月死亡。
由于其有恶变转化为HBCAC的可能,且考虑到不完全切除后易复发,因此,具有足够手术切缘的根治性切除被认为是HBCA最合适的治疗方式。